SCHEMBL6404708

SCHEMBL6404708

CC(C)(COC(=O)Nc1ccccc1C(=O)O)C(=O)OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54
ALDH1A1 P00352 3/20 0.47
ABCC1 P33527 4/20 0.46
CFD P00746 1/20 0.46
POLB P06746 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KDM4E B2RXH2 1/20 0.44
KMT2A Q03164 1/20 0.44
HCAR2 Q8TDS4 1/20 0.44
CASP3 P42574 1/20 0.43
CTSV O60911 2/20 0.42
CTSL P07711 2/20 0.42
LMNA P02545 1/20 0.42
CYP2C19 P33261 2/20 0.42
MAPT P10636 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2233522 0.84 NPC1 (0.69) NPC1RAB9AALDH1A1ABCC1CFD
SCHEMBL1537721 0.78 ALDH1A1 (0.53) NPC1RAB9AALDH1A1L3MBTL1KMT2A
SCHEMBL7835188 0.77 KDM4E (0.48) NPC1RAB9AALDH1A1ABCC1CFD
SCHEMBL5055502 0.76 NPC1 (0.58) NPC1RAB9AALDH1A1CFDHCAR2
SCHEMBL20362639 0.76 ALDH1A1 (0.64) NPC1RAB9AALDH1A1L3MBTL1KMT2A
SCHEMBL23135473 0.75 ALDH1A1 (0.53) NPC1RAB9AALDH1A1L3MBTL1KMT2A
SCHEMBL10489819 0.75 KMT2A (0.63) NPC1RAB9AALDH1A1ABCC1POLB
SCHEMBL22497489 0.75 KDM4E (0.61) NPC1RAB9AALDH1A1CFDPOLB
SCHEMBL8115672 0.75 ALDH1A1 (0.63) NPC1RAB9AALDH1A1CFDPOLB
SCHEMBL5055467 0.74 NPC1 (0.57) NPC1RAB9AALDH1A1ABCC1CFD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 NPC1 706/4885RAB9A 1891/4885ALDH1A1 408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.